AROAF (AROAF PINK) stock market data APIs
$0.518
0(0%)
as of June 12, 2026
Try our APIs with
free plan!
AROAF Financial Data Overview
Price chart is built with
Anychart
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Prev. Close
0.518
Open
0.518
High
0.518
Low
0.518
52 wk Range
0.35-0.522
Market Cap
180 M
P/E Ratio
52
Shares Outstanding
347 M
Revenue
104 M
Beta
0.843
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get AROAF data using free add-ons & libraries
Get AROAF Fundamental Data
AROAF Fundamental data includes:
- Net Revenue: 104 M
- EBITDA: 8 837 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
AROAF News
New
High Growth Tech Stocks In Australia For February 2026
As Australian shares continue their upward momentum, marking a third consecutive advance in Week 7, investors are keenly focused on February's earnings season, which is poised to influence market dyna...
ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks
The Australian market is experiencing a challenging period, with a significant downturn influenced by global market pressures and recent tech selloffs. Despite the turbulence, investors often seek opp...
3 Promising ASX Penny Stocks With Market Caps Under A$700M
The Australian market has shown resilience despite global uncertainties, with investors cautiously optimistic following recent geopolitical developments and trade discussions. In such a climate, penny...
3 ASX Penny Stocks With Market Caps Under A$400M To Watch
The Australian stock market showed mixed performance recently, with utilities and energy sectors leading gains while financials lagged behind. In this fluctuating landscape, investors may find opportu...
Get AROAF fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
